Gregory Norden
CIK 1405104 · Sr. VP and CFO · last filed 2026-06-12
Gregory Norden is a Sr. VP and CFO who has filed 88 SEC Form 4 insider transactions across 7 companies since 2008. The most recent filing, for PRAX, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.22M
7
88
-$3.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRAX | Director | 1,559 | $360.76 | $562.4K | $0 | 7 | 2026-06-12 |
| RPRX | Director | 196,348 | $56.77 | $11.15M | -$1.38M | 10 | 2026-06-08 |
| ZTS | Director | 7,071 | $72.66 | $513.8K | -$894.3K | 36 | 2026-03-10 |
| NanoString Technologies Inc (NSTG) Delisted | Director | 47,419 | $0.11 | $5.0K | -$872.1K | 18 | 2023-06-27 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Director | — | $2.19 | — | $0 | 2 | 2019-06-21 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 0 | — | — | $67.8K | 5 | 2012-08-01 |
| WYETH (WYE) Delisted | Sr. VP and CFO | 64,410 | — | — | $0 | 5 | 2009-04-28 |
Recent Filings
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | PRAX | Grant (A) | +1,371 | $0 | EDGAR |
| 2026-06-08 | RPRX | Grant (A) | +4,545 | $0 | EDGAR |
| 2026-05-15 | RPRX | Sell (S) | −3,045 | -$161.4K | EDGAR |
| 2026-05-14 | RPRX | Notice (144) | −3,045 | -$161.4K | EDGAR |
| 2026-03-10 | ZTS | Gift (G) | −1,213 | $0 | EDGAR |
| 2026-02-23 | ZTS | Mixed | +1,213 | -$51.7K | EDGAR |
| 2026-02-19 | ZTS | Grant (A) | — | $0 | EDGAR |
| 2025-08-11 | RPRX | Notice (144) | −33,500 | -$1.21M | EDGAR |
| 2025-08-11 | RPRX | Mixed | +111,160 | -$1.21M | EDGAR |
| 2025-06-27 | PRAX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.